INFANRIX hexa susp inj (n ser pré) 10 x 0.5 ml
7680006400047
Pharmacode 1108233
CH-640
J07CA09
08.08.
Active substances:
1 / 3
google
Details
- GTIN
- 7680006400047
- Pharmacode
- 1108233
- Product number
- 0064001
- CPT
- -
- Packaging group
- 10 x 1
- Unit
- Kombipackung(en)
- Composition
- I) DTPa-HepB-IPV: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.2 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80. II) Hib: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, aluminium 0.12 mg ut aluminii phosphas, pro praeparatione. I) et II) corresp. DTPa-HepB-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.32 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.
Articles (1)
Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension
Pulver
10 x 1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
toxoidum diphtheriae
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum diphtheriae
|
- | Substance | Wirkstoff (Principe actif) |
|
lactosum
|
- | Substance | HNIDK |
|
toxoidum tetani
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum tetani
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum pertussis
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
aluminium
|
0.12 MG | Substance | HBESI |
|
toxoidum pertussis
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum filamentosum
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum filamentosum
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
aluminii phosphas
|
- | Substance | HNIDK |
|
pertactinum
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
pertactinum
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 1 inactivatus
|
40.0 UI | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 1 inactivatus
|
40.0 UI | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 2 inactivatus
|
8.0 UI | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 2 inactivatus
|
8.0 UI | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 3 inactivatus
|
32.0 UI | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 3 inactivatus
|
32.0 UI | Substance | Wirkstoff (Principe actif) |
|
hepatitidis B viri antigenum ADNr
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
hepatitidis B viri antigenum ADNr
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
aluminium
|
0.5 MG | Substance | HBESI |
|
aluminii hydroxidum hydricum ad adsorptionem
|
- | Substance | HNIDK |
|
aluminium
|
0.5 MG | Substance | HBESI |
|
aluminii hydroxidum hydricum ad adsorptionem
|
- | Substance | HNIDK |
|
aluminium
|
0.2 MG | Substance | HBESI |
|
aluminii phosphas
|
- | Substance | HNIDK |
|
aluminium
|
0.32 MG | Substance | HBESI |
|
natrii chloridum
|
- | Substance | HNIDK |
|
aluminii phosphas
|
- | Substance | HNIDK |
|
natrium
|
1.8 MG | Substance | HBESI |
|
natrii chloridum
|
- | Substance | HNIDK |
|
medium 199
|
- | Substance | HNIDK |
|
natrium
|
1.8 MG | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
medium 199
|
- | Substance | HNIDK |
|
lactosum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
neomycini sulfas
|
- | Substance | RESI |
|
polymyxini B sulfas
|
- | Substance | RESI |
|
formaldehydum
|
- | Substance | RESI |
|
neomycini sulfas
|
- | Substance | RESI |
|
polymyxini B sulfas
|
- | Substance | RESI |
|
polysorbatum 20
|
- | Substance | RESI |
|
formaldehydum
|
- | Substance | RESI |
|
polysorbatum 80
|
- | Substance | RESI |
|
polysorbatum 20
|
- | Substance | RESI |
|
polysorbatum 80
|
- | Substance | RESI |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 640
- Drug name
- Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension
- Galenic form
- PULSIN
- ATC Code
- J07CA09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 02/10/2000
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INFANRIX hexa susp inj (n ser pré) 10 x 0.5 ml
- Description (DE)
- INFANRIX hexa Inj Susp (n Fertspr) 10 x 0.5 ml
- Market launch
- 02/10/2000
- Narcotic (BTM)
- No
Application methods
IMU